 | • レポートコード：GIR-107A14419 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、細胞傷害性Tリンパ球タンパク質4のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。細胞傷害性Tリンパ球タンパク質4の種類別市場規模（CG-0161、AGEN-2041、ATOR-1015、FPT-155、その他）、用途別市場規模（胃がん、黒色腫、転移性乳がん、血液腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・細胞傷害性Tリンパ球タンパク質4の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Alligator Bioscience AB、Bristol-Myers Squibb Company、Cold Genesys Inc、Crown Bioscience Inc、Five Prime Therapeutics Inc、Globavir Biosciences Inc、Humorigin Biotechnology Corp、Immunocore Ltd、Immunwork Inc、Innovent Biologics Inc、JHL Biotech Inc、MacroGenics Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：CG-0161、AGEN-2041、ATOR-1015、FPT-155、その他 ・用途別分析2016年-2026年：胃がん、黒色腫、転移性乳がん、血液腫瘍、その他 ・細胞傷害性Tリンパ球タンパク質4の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・細胞傷害性Tリンパ球タンパク質4のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・細胞傷害性Tリンパ球タンパク質4のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・細胞傷害性Tリンパ球タンパク質4の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・細胞傷害性Tリンパ球タンパク質4の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cytotoxic T Lymphocyte Protein 4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cytotoxic T Lymphocyte Protein 4 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cytotoxic T Lymphocyte Protein 4 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cytotoxic T Lymphocyte Protein 4 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CG-0161
AGEN-2041
ATOR-1015
FPT-155
Others
Market segment by Application can be divided into
Gastric Cancer
Melanoma
Metastatic Breast Cancer
Hematological Tumor
Others
The key market players for global Cytotoxic T Lymphocyte Protein 4 market are listed below:
Alligator Bioscience AB
Bristol-Myers Squibb Company
Cold Genesys Inc
Crown Bioscience Inc
Five Prime Therapeutics Inc
Globavir Biosciences Inc
Humorigin Biotechnology Corp
Immunocore Ltd
Immunwork Inc
Innovent Biologics Inc
JHL Biotech Inc
MacroGenics Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cytotoxic T Lymphocyte Protein 4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cytotoxic T Lymphocyte Protein 4, with price, sales, revenue and global market share of Cytotoxic T Lymphocyte Protein 4 from 2019 to 2021.
Chapter 3, the Cytotoxic T Lymphocyte Protein 4 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cytotoxic T Lymphocyte Protein 4 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cytotoxic T Lymphocyte Protein 4 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cytotoxic T Lymphocyte Protein 4 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cytotoxic T Lymphocyte Protein 4 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cytotoxic T Lymphocyte Protein 4 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 CG-0161
1.2.3 AGEN-2041
1.2.4 ATOR-1015
1.2.5 FPT-155
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cytotoxic T Lymphocyte Protein 4 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Gastric Cancer
1.3.3 Melanoma
1.3.4 Metastatic Breast Cancer
1.3.5 Hematological Tumor
1.3.6 Others
1.4 Global Cytotoxic T Lymphocyte Protein 4 Market Size & Forecast
1.4.1 Global Cytotoxic T Lymphocyte Protein 4 Sales in Value (2016-2026))
1.4.2 Global Cytotoxic T Lymphocyte Protein 4 Sales in Volume (2016-2026)
1.4.3 Global Cytotoxic T Lymphocyte Protein 4 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Cytotoxic T Lymphocyte Protein 4 Production Capacity Analysis
1.5.1 Global Cytotoxic T Lymphocyte Protein 4 Total Production Capacity (2016-2026)
1.5.2 Global Cytotoxic T Lymphocyte Protein 4 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cytotoxic T Lymphocyte Protein 4 Market Drivers
1.6.2 Cytotoxic T Lymphocyte Protein 4 Market Restraints
1.6.3 Cytotoxic T Lymphocyte Protein 4 Trends Analysis
2 Manufacturers Profiles
2.1 Alligator Bioscience AB
2.1.1 Alligator Bioscience AB Details
2.1.2 Alligator Bioscience AB Major Business
2.1.3 Alligator Bioscience AB Cytotoxic T Lymphocyte Protein 4 Product and Services
2.1.4 Alligator Bioscience AB Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Cytotoxic T Lymphocyte Protein 4 Product and Services
2.2.4 Bristol-Myers Squibb Company Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Cold Genesys Inc
2.3.1 Cold Genesys Inc Details
2.3.2 Cold Genesys Inc Major Business
2.3.3 Cold Genesys Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.3.4 Cold Genesys Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Crown Bioscience Inc
2.4.1 Crown Bioscience Inc Details
2.4.2 Crown Bioscience Inc Major Business
2.4.3 Crown Bioscience Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.4.4 Crown Bioscience Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Five Prime Therapeutics Inc
2.5.1 Five Prime Therapeutics Inc Details
2.5.2 Five Prime Therapeutics Inc Major Business
2.5.3 Five Prime Therapeutics Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.5.4 Five Prime Therapeutics Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Globavir Biosciences Inc
2.6.1 Globavir Biosciences Inc Details
2.6.2 Globavir Biosciences Inc Major Business
2.6.3 Globavir Biosciences Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.6.4 Globavir Biosciences Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Humorigin Biotechnology Corp
2.7.1 Humorigin Biotechnology Corp Details
2.7.2 Humorigin Biotechnology Corp Major Business
2.7.3 Humorigin Biotechnology Corp Cytotoxic T Lymphocyte Protein 4 Product and Services
2.7.4 Humorigin Biotechnology Corp Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Immunocore Ltd
2.8.1 Immunocore Ltd Details
2.8.2 Immunocore Ltd Major Business
2.8.3 Immunocore Ltd Cytotoxic T Lymphocyte Protein 4 Product and Services
2.8.4 Immunocore Ltd Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Immunwork Inc
2.9.1 Immunwork Inc Details
2.9.2 Immunwork Inc Major Business
2.9.3 Immunwork Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.9.4 Immunwork Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Innovent Biologics Inc
2.10.1 Innovent Biologics Inc Details
2.10.2 Innovent Biologics Inc Major Business
2.10.3 Innovent Biologics Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.10.4 Innovent Biologics Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 JHL Biotech Inc
2.11.1 JHL Biotech Inc Details
2.11.2 JHL Biotech Inc Major Business
2.11.3 JHL Biotech Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.11.4 JHL Biotech Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 MacroGenics Inc
2.12.1 MacroGenics Inc Details
2.12.2 MacroGenics Inc Major Business
2.12.3 MacroGenics Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
2.12.4 MacroGenics Inc Cytotoxic T Lymphocyte Protein 4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cytotoxic T Lymphocyte Protein 4 Sales by Manufacturer
3.1 Global Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cytotoxic T Lymphocyte Protein 4 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cytotoxic T Lymphocyte Protein 4
3.4 Market Concentration Rate
3.4.1 Top 3 Cytotoxic T Lymphocyte Protein 4 Manufacturer Market Share
3.4.2 Top 6 Cytotoxic T Lymphocyte Protein 4 Manufacturer Market Share
3.5 Global Cytotoxic T Lymphocyte Protein 4 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cytotoxic T Lymphocyte Protein 4 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cytotoxic T Lymphocyte Protein 4 Market Size by Region
4.1.1 Global Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Region (2016-2026)
4.1.2 Global Cytotoxic T Lymphocyte Protein 4 Revenue by Region (2016-2026)
4.2 North America Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026)
4.3 Europe Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026)
4.4 Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026)
4.5 South America Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026)
4.6 Middle East and Africa Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Type (2016-2026)
5.2 Global Cytotoxic T Lymphocyte Protein 4 Revenue by Type (2016-2026)
5.3 Global Cytotoxic T Lymphocyte Protein 4 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Application (2016-2026)
6.2 Global Cytotoxic T Lymphocyte Protein 4 Revenue by Application (2016-2026)
6.3 Global Cytotoxic T Lymphocyte Protein 4 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2026)
7.2 North America Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2026)
7.3 North America Cytotoxic T Lymphocyte Protein 4 Market Size by Country
7.3.1 North America Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Country (2016-2026)
7.3.2 North America Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2026)
8.2 Europe Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2026)
8.3 Europe Cytotoxic T Lymphocyte Protein 4 Market Size by Country
8.3.1 Europe Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Country (2016-2026)
8.3.2 Europe Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2026)
9.2 Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2026)
9.3 Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Market Size by Region
9.3.1 Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2026)
10.2 South America Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2026)
10.3 South America Cytotoxic T Lymphocyte Protein 4 Market Size by Country
10.3.1 South America Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Country (2016-2026)
10.3.2 South America Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2026)
11.2 Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2026)
11.3 Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Market Size by Country
11.3.1 Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cytotoxic T Lymphocyte Protein 4 Typical Distributors
12.3 Cytotoxic T Lymphocyte Protein 4 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Application, (USD Million), 2021-2026
Table 3. Alligator Bioscience AB Basic Information, Manufacturing Base and Competitors
Table 4. Alligator Bioscience AB Major Business
Table 5. Alligator Bioscience AB Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 6. Alligator Bioscience AB Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 10. Bristol-Myers Squibb Company Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cold Genesys Inc Basic Information, Manufacturing Base and Competitors
Table 12. Cold Genesys Inc Major Business
Table 13. Cold Genesys Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 14. Cold Genesys Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Crown Bioscience Inc Basic Information, Manufacturing Base and Competitors
Table 16. Crown Bioscience Inc Major Business
Table 17. Crown Bioscience Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 18. Crown Bioscience Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Five Prime Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 20. Five Prime Therapeutics Inc Major Business
Table 21. Five Prime Therapeutics Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 22. Five Prime Therapeutics Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Globavir Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 24. Globavir Biosciences Inc Major Business
Table 25. Globavir Biosciences Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 26. Globavir Biosciences Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Humorigin Biotechnology Corp Basic Information, Manufacturing Base and Competitors
Table 28. Humorigin Biotechnology Corp Major Business
Table 29. Humorigin Biotechnology Corp Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 30. Humorigin Biotechnology Corp Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Immunocore Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Immunocore Ltd Major Business
Table 33. Immunocore Ltd Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 34. Immunocore Ltd Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Immunwork Inc Basic Information, Manufacturing Base and Competitors
Table 36. Immunwork Inc Major Business
Table 37. Immunwork Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 38. Immunwork Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Innovent Biologics Inc Basic Information, Manufacturing Base and Competitors
Table 40. Innovent Biologics Inc Major Business
Table 41. Innovent Biologics Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 42. Innovent Biologics Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. JHL Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 44. JHL Biotech Inc Major Business
Table 45. JHL Biotech Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 46. JHL Biotech Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. MacroGenics Inc Basic Information, Manufacturing Base and Competitors
Table 48. MacroGenics Inc Major Business
Table 49. MacroGenics Inc Cytotoxic T Lymphocyte Protein 4 Product and Services
Table 50. MacroGenics Inc Cytotoxic T Lymphocyte Protein 4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Cytotoxic T Lymphocyte Protein 4 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 52. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Cytotoxic T Lymphocyte Protein 4, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Cytotoxic T Lymphocyte Protein 4 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 55. Head Office and Cytotoxic T Lymphocyte Protein 4 Production Site of Key Manufacturer
Table 56. Cytotoxic T Lymphocyte Protein 4 New Entrant and Capacity Expansion Plans
Table 57. Cytotoxic T Lymphocyte Protein 4 Mergers & Acquisitions in the Past Five Years
Table 58. Global Cytotoxic T Lymphocyte Protein 4 Sales by Region (2016-2021e) & (K Pcs)
Table 59. Global Cytotoxic T Lymphocyte Protein 4 Sales by Region (2021-2026) & (K Pcs)
Table 60. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2021e) & (K Pcs)
Table 63. Global Cytotoxic T Lymphocyte Protein 4 Sales by Type (2021-2026) & (K Pcs)
Table 64. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Cytotoxic T Lymphocyte Protein 4 Price by Type (2016-2021e) & (USD/Pcs)
Table 67. Global Cytotoxic T Lymphocyte Protein 4 Price by Type (2021-2026) & (USD/Pcs)
Table 68. Global Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2021e) & (K Pcs)
Table 69. Global Cytotoxic T Lymphocyte Protein 4 Sales by Application (2021-2026) & (K Pcs)
Table 70. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Cytotoxic T Lymphocyte Protein 4 Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Cytotoxic T Lymphocyte Protein 4 Price by Application (2016-2021e) & (USD/Pcs)
Table 73. Global Cytotoxic T Lymphocyte Protein 4 Price by Application (2021-2026) & (USD/Pcs)
Table 74. North America Cytotoxic T Lymphocyte Protein 4 Sales by Country (2016-2021e) & (K Pcs)
Table 75. North America Cytotoxic T Lymphocyte Protein 4 Sales by Country (2021-2026) & (K Pcs)
Table 76. North America Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2021e) & (K Pcs)
Table 79. North America Cytotoxic T Lymphocyte Protein 4 Sales by Type (2021-2026) & (K Pcs)
Table 80. North America Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2021e) & (K Pcs)
Table 81. North America Cytotoxic T Lymphocyte Protein 4 Sales by Application (2021-2026) & (K Pcs)
Table 82. Europe Cytotoxic T Lymphocyte Protein 4 Sales by Country (2016-2021e) & (K Pcs)
Table 83. Europe Cytotoxic T Lymphocyte Protein 4 Sales by Country (2021-2026) & (K Pcs)
Table 84. Europe Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2021e) & (K Pcs)
Table 87. Europe Cytotoxic T Lymphocyte Protein 4 Sales by Type (2021-2026) & (K Pcs)
Table 88. Europe Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2021e) & (K Pcs)
Table 89. Europe Cytotoxic T Lymphocyte Protein 4 Sales by Application (2021-2026) & (K Pcs)
Table 90. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Region (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Region (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2021e) & (K Pcs)
Table 95. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Type (2021-2026) & (K Pcs)
Table 96. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2021e) & (K Pcs)
Table 97. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales by Application (2021-2026) & (K Pcs)
Table 98. South America Cytotoxic T Lymphocyte Protein 4 Sales by Country (2016-2021e) & (K Pcs)
Table 99. South America Cytotoxic T Lymphocyte Protein 4 Sales by Country (2021-2026) & (K Pcs)
Table 100. South America Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2021e) & (K Pcs)
Table 103. South America Cytotoxic T Lymphocyte Protein 4 Sales by Type (2021-2026) & (K Pcs)
Table 104. South America Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2021e) & (K Pcs)
Table 105. South America Cytotoxic T Lymphocyte Protein 4 Sales by Application (2021-2026) & (K Pcs)
Table 106. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Country (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Country (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Type (2016-2021e) & (K Pcs)
Table 111. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Type (2021-2026) & (K Pcs)
Table 112. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Application (2016-2021e) & (K Pcs)
Table 113. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales by Application (2021-2026) & (K Pcs)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Cytotoxic T Lymphocyte Protein 4 Typical Distributors
Table 117. Cytotoxic T Lymphocyte Protein 4 Typical Customers
List of Figures
Figure 1. Cytotoxic T Lymphocyte Protein 4 Picture
Figure 2. Global Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Type in 2020
Figure 3. CG-0161
Figure 4. AGEN-2041
Figure 5. ATOR-1015
Figure 6. FPT-155
Figure 7. Others
Figure 8. Global Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Application in 2020
Figure 9. Gastric Cancer
Figure 10. Melanoma
Figure 11. Metastatic Breast Cancer
Figure 12. Hematological Tumor
Figure 13. Others
Figure 14. Global Cytotoxic T Lymphocyte Protein 4 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Cytotoxic T Lymphocyte Protein 4 Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Cytotoxic T Lymphocyte Protein 4 Sales (2016-2026) & (K Pcs)
Figure 17. Global Cytotoxic T Lymphocyte Protein 4 Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Cytotoxic T Lymphocyte Protein 4 Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Cytotoxic T Lymphocyte Protein 4 Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Cytotoxic T Lymphocyte Protein 4 Market Drivers
Figure 21. Cytotoxic T Lymphocyte Protein 4 Market Restraints
Figure 22. Cytotoxic T Lymphocyte Protein 4 Market Trends
Figure 23. Global Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Manufacturer in 2020
Figure 24. Global Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Manufacturer in 2020
Figure 25. Cytotoxic T Lymphocyte Protein 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Cytotoxic T Lymphocyte Protein 4 Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Cytotoxic T Lymphocyte Protein 4 Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Region (2016-2026)
Figure 29. Global Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Region (2016-2026)
Figure 30. North America Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026) & (USD Million)
Figure 31. Europe Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026) & (USD Million)
Figure 33. South America Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Revenue (2016-2026) & (USD Million)
Figure 35. Global Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Type (2016-2026)
Figure 36. Global Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Type (2016-2026)
Figure 37. Global Cytotoxic T Lymphocyte Protein 4 Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Application (2016-2026)
Figure 39. Global Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Application (2016-2026)
Figure 40. Global Cytotoxic T Lymphocyte Protein 4 Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Type (2016-2026)
Figure 42. North America Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Application (2016-2026)
Figure 43. North America Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Country (2016-2026)
Figure 44. North America Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Country (2016-2026)
Figure 45. United States Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Type (2016-2026)
Figure 49. Europe Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Application (2016-2026)
Figure 50. Europe Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Country (2016-2026)
Figure 51. Europe Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Country (2016-2026)
Figure 52. Germany Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Region (2016-2026)
Figure 61. China Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Type (2016-2026)
Figure 68. South America Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Application (2016-2026)
Figure 69. South America Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Country (2016-2026)
Figure 70. South America Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Cytotoxic T Lymphocyte Protein 4 Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Cytotoxic T Lymphocyte Protein 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のTリンパ球活性化抗原CD86市場 2021：企業別、地域別、種類・用途別 The T Lymphocyte Activation Antigen CD86 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 世界の細胞障害性薬物陽安全キャビネット市場 2021：企業別、地域別、種類・用途別 The Cytotoxic Drug Safety Cabinet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のTリンパ球活性化抗原CD80市場 2021：企業別、地域別、種類・用途別 The T Lymphocyte Activation Antigen CD80 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の細胞分裂周期7相同体タンパク質キナーゼ市場 2021：企業別、地域別、種類・用途別 The Cell Division Cycle 7 Related Protein Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界のセリンプロテインキナーゼ市場 2021：企業別、地域別、種類・用途別 The Serine Protein Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…